Dr. Emran Ghaffar Khan

Dr. Emran Khan is a Consultant Endocrinologist and Clinical Director of KIDEO, King's Institute of Diabetes, Endocrinology and Obesity at King's College Hospital London in Dubai. He qualified in 1986 and brings more than 30 years of specialist experience in diabetes, endocrinology, obesity medicine, thyroid disease, and complex hormonal disorders. He completed postgraduate training across major UK teaching hospitals including Leicester Royal Infirmary, Nottingham City University Hospital, Northern General Hospital Sheffield, and holds dual Fellowship of the Royal College of Physicians in both London and Edinburgh.

Dr. Khan founded KIDEO from a single-handed practice into a multidisciplinary institute, personally recruiting seven UK-trained consultants and leading its clinical direction and service development. His practice covers the full spectrum of endocrine and metabolic medicine with particular expertise in type 1 and type 2 diabetes, obesity, thyroid disorders (nodules, cancer, Graves' disease, Hashimoto's), pituitary and adrenal disorders, PCOS, parathyroid disease, and men's hormonal health. He was the first physician outside the United States to prescribe tirzepatide (Mounjaro) and orforglipron (Foundayo), reflecting KIDEO's position in next-generation metabolic care.

Dr. Khan established and chairs a weekly multidisciplinary team meeting for thyroid cancer and complex endocrine cases, bringing together a 12-specialist panel for coordinated case discussion and treatment planning. He has a strong interest in medical weight management using evidence-based therapies, longevity-focused metabolic care, and teaching and mentoring doctors in endocrinology and diabetes. He is an Adjunct Clinical Associate Professor with a Postgraduate Diploma in Medical Leadership.